Field Trip continues its U.S. expansion with opening of a new clinic in Atlanta.
Exploring the companies and themes that make up this emerging and exciting new sector
Psychedelics ETF to Launch After Sector Attracts Thiel’s Money
The world’s first exchange-traded fund for psychedelic-drug companies will debut this week in Toronto, as the investment industry tries to capitalize on rising interest in prospective mental health treatments using the drugs.
Follow The Money: US$500+ Million In New Psychedelics Financing Powering Massive Growth
It's not just how much money that is being raised by psychedelic drug companies. It's HOW they are doing it.
How the psychedelic Ibogaine helped a retired Vancouver firefighter treat his depression
In an interview with City News, a retired firefighter and rescue member from Vancouver says that Iboga, a psychedelic rainforest shrub that grows across West Africa, saved his life.
Psychedelics Revolution Gaining Breadth And Momentum
As trading in psychedelic stocks begins to heat up (again), the emerging psychedelic drug industry is growing rapidly -- vertically and horizontally.
Cannabis compliance firm Allay Consulting adds psilocybin offering
Allay Consulting, a Portland, OR-based firm specializing in cannabis regulatory compliance consulting, has announced a new division to deliver regulatory compliance services in the legal therapeutic psilocybin market in Oregon, as well as other jurisdictions that follow suit.
Mind Cure Health Inc. Announces an Increase to Previously Announced Bought Deal Public Offering
Mind Cure has upsized its bought deal financing by DOUBLE to CAD$20 million.
Numinus Announces Listing of New Warrants
Numinus announces the listing of its latest series of warrants for public trading, under the symbol "NUMI.WS". Warrants have an exercise price of CAD$0.90 and are valid until December 29, 2022.
Beckley Foundation: The Major Psychedelics Non-Profit Across The Pond
The UK-based Beckley Foundation is a psychedelics non-profit founded over 20 years ago that is having an increasing impact on the Psychedelics Revolution.
The first-ever psychedelics ETF will launch next week, backed by a Canadian fund manager
The first-ever psychedelics ETF will begin trading on the Canadian NEO exchange next Wednesday, giving investors exposure to publicly-traded companies focused on the development of therapeutic solutions that utilize psychedelics.
Psyched Wellness Announces C$3M Bought Deal Private Placement Led by Canaccord Genuity
Psyched Wellness announces a CAD$3 million bought deal with units priced at CAD$0.31.
Albert Labs inks LOI to undergo reverse takeover of ME Resource in move to expand access to psychedelics
Albert Labs, a privately held psychedelic drug developer, signed a letter of intent (LOI) on January 5 to be acquired by ME Resource Corp (CSE:MEC) (OTC:MEEXF), the latter company announced.